Navigation Links
Vaccine against grass pollen allergy introduced by ALK-Abell

Patients in Germany who suffer from allergy to grass pollen will now benefit from a suitable vaccine against it. The newly introduced, tablet based //vaccine named Grazax? is being marketed by ALK-Abelló, a public limited company focusing on allergy treatment.

Allergy from grass pollen prominently disrupts quality of life affecting concentration at work or school dampening social interaction severely .Statistics reveal that over 45 million Europeans suffer from this allergy which leads to allergic rhinitis(hay fever) or allergic asthma.

The CEO of ALK-Abelló informed media that Grazax? is the result of years of dedicated research. Since the immunotherapy vaccine is formulated in a tablet form, it is feasible and convenient to patients for treatment at home.Grazax? is to be used as a single dose daily .The company has informed that optimum benefits are achieved if the tablets are taken about 8 weeks prior to onset of the season when grass pollen becomes rampant.

82% of patients, who underwent treatment for grass pollen allergy using Grazax?, reported a definite sense of well being. Previously they had never received any treatment whatsoever.

The company officials have also announced that this vaccine will soon be introduced to other European nations as well, where the company has subsidiary units.
MS
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vaccine against grass pollen allergy introduced ALK Abell

(Date:9/17/2014)... Steven Reinberg HealthDay Reporter ... uncovered a key factor to explain why antibiotic-resistant bacteria can ... DNA called plasmids appear to be the culprit. They can ... and some carry a gene that makes bacteria drug-resistant, a ... carry an antibiotic-resistant gene to a class of antibiotic called ...
(Date:9/17/2014)... able to reduce the need for invasive biopsies in ... lupus. , In a new study, researchers developed a ... kidney inflammation to interstitial fibrosis, scarring in ... biopsy is the only existing way to reach a ... The model could also be used to monitor the ...
(Date:9/17/2014)... September 17, 2014 Today, Blue ... million in third-quarter grantmaking. This body of grants aims ... spreading innovations in care delivery, as well as to ... uninsured. Grants will also strengthen the capacity of both ... responsive and create new entry points for domestic violence ...
(Date:9/17/2014)... 2014 In a country where 77% ... a regular basis, how can Americans find healthy and ... Hyland’s Stress Challenge , a 5-day interactive journey to ... life. From September 29th – October 3rd, the ... relating to specific topics that promote natural solutions for ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... confirmed cases of Enterovirus D68, the severe respiratory illnesses ... officials report. Alabama, Colorado, Illinois, Indiana, Iowa, Kansas, ... have 130 laboratory-confirmed cases of Enterovirus D68, according to ... The virus, part of the family of viruses that ...
Breaking Medicine News(10 mins):Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3Health News:Math model designed to replace invasive kidney biopsy for lupus patients 2Health News:Blue Shield of California Foundation Awards $5 Million in Third-Quarter Grants 2Health News:Stress Less with the Hyland's 5-Day Stress Challenge 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 2Health News:12 States Now Reporting Severe Respiratory Illness That Targets Kids 3
... , WEDNESDAY, Feb. 9 (HealthDay News) -- The number ... attempts swings sharply depending on what month it is, a ... for men aged 50 and older, while there was little ... the report from the Substance Abuse and Mental Health Services ...
... many patients realise that diabetes can affect their kidneys is ... multi-cultural study in the March issue of the Journal ... to 48 patients with diabetes attending specialist renal services in ... risks posed by the disease was very low. ...
... Researchers from the Hospital Virgen de las Nieves of ... frequent mutations in the gene KCNH2 in patients with long ... cardiac ionic channels that approximately affects one in every 2,500 ... trigger sudden death. This condition usually affects children and adolescents, ...
... Sciences Discovery Fund (LSDF) today announced nearly $600,000 in ... the diagnosis and management of major health conditions. ... producing novel tests to diagnose or monitor disease. Jane ... a Washington-based company, will adapt a novel air sampling ...
... HealthDay Reporter , TUESDAY, Feb. 8 (HealthDay News) -- Men ... bearing children with congenital problems such as a cleft palate compared ... research. But the overall risk was low, researchers from Sweden ... of the National Cancer Institute . And the findings ...
... at the University at Buffalo have devised two new ... important molecules from losing their shape and degrading in ... the development of peptide-based drugs against diseases including cancer. ... than existing techniques, one of which employs an expensive ...
Cached Medicine News:Health News:Males' Drug-Related Suicide Attempts Vary by Month 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 2Health News:Experts call for greater awareness of the links between diabetes and kidney disease 3Health News:Researchers identify the genotype of disorders causing cardiac sudden death syndrome 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 2Health News:Washington Life Sciences Discovery Fund announces grants to commercialize promising technologies 3Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 2Health News:Birth Defect Risk Slightly Higher for Kids of Male Cancer Survivors 3Health News:New techniques for stapling peptides could spur development of drugs for cancer 2
(Date:9/17/2014)... Sept. 17, 2014 Bronstein, Gewirtz & Grossman, ... of the securities of PDL BioPharma, Inc. ("PDL BioPharma" ... Such investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. ... of its executives violated federal securities laws. ...
(Date:9/17/2014)... September 17, 2014 ... has shown positive data in a Phase 2a proof ... , Glenmark Pharmaceuticals today announced ... 1 (TRPA1) antagonist, GRC 17536 has shown positive data ... proof of concept study conducted on 138 patients in ...
(Date:9/17/2014)... 2014   MedeAnalytics today unveils Revenue ... complete visibility to a provider,s "mid-cycle" to optimize ... landscape. Powered by the industry,s leading big data ... point between patient access and the business office ... improve revenue capture, minimize audit risk and prepare ...
Breaking Medicine Technology:Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... New study finds patients who opt for surgery have decreased pain, ... with the spine disease called degenerative spondylolisthesis * ... pain over time compared to those who do not have surgery, ... The Journal of Bone and Joint Surgery ...
... GAITHERSBURG, Md., June 1 Overall survival data in ... GenVec,s ongoing Phase III Pancreatic Cancer Clinical Trial with ... Society of Clinical Oncology Annual Meeting in Orlando, FL. ... ) , , The poster ...
Cached Medicine Technology:Back to Normal: Surgery Improves Outcomes for Spine Patients 2Back to Normal: Surgery Improves Outcomes for Spine Patients 3Back to Normal: Surgery Improves Outcomes for Spine Patients 4TNFerade(TM) Phase III Data Presented at ASCO 2TNFerade(TM) Phase III Data Presented at ASCO 3
... Pulse Oximeter monitors SpO2, pulse ... is designed to provide fast, ... The device rejects spontaneous motion ... operator of excess artifacts and ...
... Radical can operate in two additional ... be removed, creating a fully featured handheld ... also be used to upgrade existing equipment ... additinal hardware or software upgrades to improve ...
Halogen-free immersion oil based on ester oil....
Immersion Oil, 150 cs...
Medicine Products: